Holen Sie sich die Stockscreener-App
34.40
0.82%
0.3147
Schlusskurs vom Vortag:
$34.09
Offen:
$34.09
24-Stunden-Volumen:
70,910
Relative Volume:
0.07
Marktkapitalisierung:
$5.40B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
54.04
EPS:
0.6367
Netto-Cashflow:
-
1W Leistung:
-6.78%
1M Leistung:
-12.92%
6M Leistung:
+345.78%
1J Leistung:
+172.78%
1-Tages-Spanne:
$33.72
$34.66
1-Wochen-Bereich:
$33.26
$38.47
52-Wochen-Spanne:
$7.50
$43.08
Pacs Group Inc Stock (PACS) Company Profile
Firmenname
Pacs Group Inc
Sektor
Branche
Telefon
(801) 447-9829
Adresse
90 S. 400 W. SUITE 700, SALT LAKE CITY
Compare PACS vs HCA, THC, FMS, ENSG, UHS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PACS
Pacs Group Inc
|
34.36 | 5.36B | 0 | 0 | 0 | 0.6367 |
|
HCA
Hca Healthcare Inc
|
538.86 | 121.90B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
240.79 | 20.92B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.17 | 13.08B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
ENSG
Ensign Group Inc
|
210.96 | 12.20B | 4.11B | 239.98M | 193.10M | 4.12 |
|
UHS
Universal Health Services Inc
|
189.81 | 11.64B | 16.08B | 1.20B | 1.06B | 17.82 |
Pacs Group Inc Stock (PACS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-17 | Fortgesetzt | JP Morgan | Overweight |
| 2024-12-17 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-11-06 | Fortgesetzt | JP Morgan | Overweight |
| 2024-10-09 | Eingeleitet | UBS | Buy |
| 2024-09-11 | Fortgesetzt | Citigroup | Buy |
| 2024-06-28 | Eingeleitet | Macquarie | Outperform |
| 2024-05-06 | Eingeleitet | Citigroup | Buy |
| 2024-05-06 | Eingeleitet | JP Morgan | Overweight |
| 2024-05-06 | Eingeleitet | Oppenheimer | Outperform |
| 2024-05-06 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-05-06 | Eingeleitet | Stephens | Overweight |
| 2024-05-06 | Eingeleitet | Truist | Buy |
Alle ansehen
Pacs Group Inc Aktie (PACS) Neueste Nachrichten
2026-03-08 | PACS Group, Inc. (PACS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation | NYSE:PACS | Press Release - Stockhouse
Pacs (PACS) Hits 52-Week High on Q3 Blowout - MSN
PACS Group, Inc. 8-K Filing: Company Information, Common Stock Trading Details, and SEC Compliance Disclosure (March 2026) - Minichart
PACS Group adds former CMS official Patrick Conway to board - Investing.com
PACS Group Appoints Patrick Conway to Board of Directors - TipRanks
PACS Group adds former CMS official Patrick Conway to board By Investing.com - Investing.com Australia
Bronstein, Gewirtz & Grossman, LLC Encourages PACS Group, Inc. (PACS) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
PACS vs. MEDP: Which Stock Is the Better Value Option? - Bitget
Does PACS Group, Inc. (PACS) Have the Potential to Rally 25.45% as Wall Street Analysts Expect? - Finviz
PACS Group Appoints Dr. Patrick Conway to Board - National Today
Pacs Group, Inc. appoints Dr. Patrick Conway, MD, MSc to board of directors - marketscreener.com
Best Momentum Stock to Buy for March 5th - Yahoo Finance Australia
PACS Group, Inc. Appoints Dr. Patrick Conway, MD, MSc to Board of Directors - Yahoo Finance
Best Value Stock to Buy for March 5th - Yahoo Finance
A Look At PACS Group (PACS) Valuation After Record 2025 Results And New 2026 Guidance - simplywall.st
5 Analysts Assess PACS Group: What You Need To Know - Benzinga
PACS Stock Receives Updated "Buy" Rating from UBS Today | PACS S - GuruFocus
PACS Group (NYSE:PACS) Price Target Raised to $44.00 at UBS Group - MarketBeat
UBS Adjusts PACS Group Price Target to $44 From $42, Maintains Buy Rating - marketscreener.com
PACS Group Inc (PACS) Shares Up 2.9% on Mar 4 - GuruFocus
Oppenheimer Adjusts Price Target on PACS Group to $42 From $40, Maintains Outperform Rating - marketscreener.com
PACS Group (NYSE:PACS) Price Target Raised to $42.00 at Oppenheimer - MarketBeat
PACS Group (PACS) awards 30,000 restricted stock units to Chief Compliance Officer - Stock Titan
PACS Group (NASDAQ: PACS) awards 25,000 RSUs to HR chief - Stock Titan
PACS (PACS) logs Form 3 insider status for Chief Compliance Officer - Stock Titan
PACS Group (PACS) HR chief Bingham Trent Dean files initial Form 3 - Stock Titan
PACS Group, Inc. (PACS) Stock Analysis: A Promising 20.63% Upside in the Healthcare Sector - DirectorsTalk Interviews
PACS Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
PACS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
RBC Capital raises PACS Group stock price target on strong guidance - Investing.com UK
RBC Raises Price Target on PACS Group to $52 From $47, Keeps Outperform Rating - marketscreener.com
PACS Group, Inc. $PACS Shares Purchased by Royce & Associates LP - MarketBeat
PACS Group, Inc. (NYSE:PACS) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Is PACS Group’s (PACS) Aggressive Acquisition Plan Strengthening Its Core Skilled Nursing Advantage? - Sahm
Long-term care’s new rock stars are changing the tune - McKnight's Long-Term Care News
PACS Group Stock Drops 12% Despite Record Profits: Event: Do Analysts See a Recovery in 2026? - TIKR.com
PACS Group (PACS) Margin Jump To 3.6% Tests Rich 29.9x P/E Narrative - simplywall.st
PACS Group Q4 Earnings Call Highlights - MarketBeat
PACS Group’s Expansion And ESOP Move Test Growth And Execution Story - Yahoo Finance
PACS Group ESOP Shelf Spurs Questions On Dilution And Staff Alignment - Sahm
Assessing PACS Group (PACS) Valuation After Strong Long Term Returns And Recent Share Price Pullback - Yahoo Finance
PACS Group Inc (PACS) Gets a Buy from RBC Capital - The Globe and Mail
Decoding PACS Group Inc (PACS): A Strategic SWOT Insight - GuruFocus
Truist raises PACS Group stock price target to $50 on margin strength - Investing.com Australia
PACS Should I Buy - Intellectia AI
PACS Group (PACS) Receives Updated Analyst Rating from RBC Capital | PACS Stock News - GuruFocus
PACS Group (NYSE:PACS) Given New $52.00 Price Target at Royal Bank Of Canada - MarketBeat
PACS Group (NYSE:PACS) Shares Gap DownWhat's Next? - MarketBeat
Pacs Group price target raised to $52 from $47 at RBC Capital - TipRanks
PACS : Q4 2025 Earnings Presentation - marketscreener.com
Truist Securities Adjusts Price Target on PACS Group to $50 From $48, Maintains Buy Rating - marketscreener.com
Finanzdaten der Pacs Group Inc-Aktie (PACS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.47%
0.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):